These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 24378915)

  • 21. Using the weighted area under the net benefit curve for decision curve analysis.
    Talluri R; Shete S
    BMC Med Inform Decis Mak; 2016 Jul; 16():94. PubMed ID: 27431531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index.
    Hilden J; Gerds TA
    Stat Med; 2014 Aug; 33(19):3405-14. PubMed ID: 23553436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating a new marker for risk prediction using the test tradeoff: an update.
    Baker SG; Van Calster B; Steyerberg EW
    Int J Biostat; 2012 Mar; 8(1):. PubMed ID: 22499728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incorporation of a genetic factor into an epidemiologic model for prediction of individual risk of lung cancer: the Liverpool Lung Project.
    Raji OY; Agbaje OF; Duffy SW; Cassidy A; Field JK
    Cancer Prev Res (Phila); 2010 May; 3(5):664-9. PubMed ID: 20424129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simple Decision-Analytic Functions of the AUC for Ruling Out a Risk Prediction Model and an Added Predictor.
    Baker SG
    Med Decis Making; 2018 Feb; 38(2):225-234. PubMed ID: 29025299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First things first: risk model performance metrics should reflect the clinical application.
    Kerr KF; Janes H
    Stat Med; 2017 Dec; 36(28):4503-4508. PubMed ID: 29156498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The high-density lipoprotein-adjusted SCORE model worsens SCORE-based risk classification in a contemporary population of 30,824 Europeans: the Copenhagen General Population Study.
    Mortensen MB; Afzal S; Nordestgaard BG; Falk E
    Eur Heart J; 2015 Sep; 36(36):2446-53. PubMed ID: 26082084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Net Reclassification Improvement.
    Jewell ES; Maile MD; Engoren M; Elliott M
    Anesth Analg; 2016 Mar; 122(3):818-824. PubMed ID: 26891393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Net risk reclassification p values: valid or misleading?
    Pepe MS; Janes H; Li CI
    J Natl Cancer Inst; 2014 Apr; 106(4):dju041. PubMed ID: 24681599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical utility curve: a proposal to improve the translation of information provided by prediction models to clinicians.
    Campbell DJ
    BMC Res Notes; 2016 Apr; 9():219. PubMed ID: 27080381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Graphical representations and summary indicators to assess the performance of risk predictors.
    Antolini L; Tassistro E; Valsecchi MG; Bernasconi DP
    Biom J; 2019 Nov; 61(6):1417-1429. PubMed ID: 30290002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.
    Pencina MJ; D'Agostino RB; Steyerberg EW
    Stat Med; 2011 Jan; 30(1):11-21. PubMed ID: 21204120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic thresholds and a summary ROC curve: Assessing prognostic accuracy of longitudinal markers.
    Saha-Chaudhuri P; Heagerty PJ
    Stat Med; 2018 Aug; 37(18):2700-2714. PubMed ID: 29671890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk prediction of incident coronary heart disease in The Netherlands: re-estimation and improvement of the SCORE risk function.
    Merry AH; Boer JM; Schouten LJ; Ambergen T; Steyerberg EW; Feskens EJ; Verschuren WM; Gorgels AP; van den Brandt PA
    Eur J Prev Cardiol; 2012 Aug; 19(4):840-8. PubMed ID: 21551214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of biomarker data: logs, odds ratios, and receiver operating characteristic curves.
    Grund B; Sabin C
    Curr Opin HIV AIDS; 2010 Nov; 5(6):473-9. PubMed ID: 20978390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide.
    Leening MJ; Vedder MM; Witteman JC; Pencina MJ; Steyerberg EW
    Ann Intern Med; 2014 Jan; 160(2):122-31. PubMed ID: 24592497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do apolipoproteins improve coronary risk prediction in subjects with metabolic syndrome? Insights from the North Italian Brianza cohort study.
    Gianfagna F; Veronesi G; Guasti L; Chambless LE; Brambilla P; Corrao G; Mancia G; Cesana G; Ferrario MM
    Atherosclerosis; 2014 Sep; 236(1):175-81. PubMed ID: 25062081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating the predictiveness of a marker with its performance as a classifier.
    Pepe MS; Feng Z; Huang Y; Longton G; Prentice R; Thompson IM; Zheng Y
    Am J Epidemiol; 2008 Feb; 167(3):362-8. PubMed ID: 17982157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study.
    Cooper JA; Miller GJ; Humphries SE
    Atherosclerosis; 2005 Jul; 181(1):93-100. PubMed ID: 15939059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statistical methods for assessment of added usefulness of new biomarkers.
    Pencina MJ; D'Agostino RB; Vasan RS
    Clin Chem Lab Med; 2010 Dec; 48(12):1703-11. PubMed ID: 20716010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.